Touching Base - GEN - Genetic Engineering and Biotechnology News

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Artificial Intelligence

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

Genome Editing

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Artificial Intelligence

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases

Artificial Intelligence

Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

Artificial Intelligence

Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine

A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News

Artificial Intelligence

A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News

AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships

Artificial Intelligence

AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships

Remembering J. Craig Venter, PhD

Genome Editing

Remembering J. Craig Venter, PhD

AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains

Artificial Intelligence

AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains

Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge

Artificial Intelligence

Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge